L 687901
Alternative Names: Tetrahydroechinocandin BLatest Information Update: 19 Nov 2001
Price :
$50 *
At a glance
- Originator Merck & Co
- Class Antifungals
- Mechanism of Action Glucan synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 19 Nov 2001 No-Development-Reported for Candidiasis in USA (Unknown route)
- 07 Nov 1994 No-Development-Reported for Mycoses in USA (Unknown route)